T1	Participants 81 145	patients with unresectable squamous cell cancer of the esophagus
T2	Participants 307 371	patients with unresectable squamous cell cancer of the esophagus
T3	Participants 582 658	Following the first 3 years of recruitment, due to unexpected late morbidity
T4	Participants 894 906	125 patients
